Tuberous sclerosis complex is an autosomal dominant multisystem disorder. Spontaneous mutations occur in up to 60% of patients with gene loci located on chromosomes 9q34 ( TSC1) and 16p13 (TSC2). Diagnosis is established with the identification of various neurocutaneous markers and multiple organ system hamartomas. The variable expression of severity, the potential for cognitive dysfunction, and epilepsy compound the clinical picture. The intracranial abnormalities include the identification of migration and hamartomatous brain lesions, such as tubers, subependymal nodules, and subependymal giant cell astrocytomas. A number of other neuroimaging and morphometric abnormalities coexist, which can be identified with current neuroimaging techniques. This review examines the spectrum of brain abnormalities encountered in tuberous sclerosis complex and presents them as not merely a collection of lesions but more cohesively in the context of a global neuronal migration disorder. (J Child Neurol 2004;19:650—657).
Get full access to this article
View all access options for this article.
References
1.
Osborne JP, Fnyer A., Webb D.: Epidemiology of tuberous sclerosis. Ann N Y Acad Sci1991;615:125—127.
2.
Hyman MH, Whittemore VH: National Institutes of Health Consensus Conference: The tuberous sclerosis complex. Arch Neurol2000;57:662—665.
Van Slegtenhorst M., de Hoogt R., Hermans C., et al: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science1997 ;227:805—808.
5.
EuropeanTuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell1993;75:1305—1315.
6.
Dabora SL, Joswiak S., Franz DN, et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of disease in multiple organs in TSC2, compared to TSC1. Am J Hum Genet2001;68:64—80.
7.
Lamb RF, Roy C., Dienfenbach TJ, et al: The TSC1 tumor suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol2000;2:289—287.
8.
Cheadle J., Reeve M., Samson J., Kwaitkowski D.: Molecular genetic advances in tuberous sclerosis. Hum Genet2002;62:345—357.
9.
Kwaitkowski DJ: Rhebbing up in TOR. New insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Cancer Biol Ther2003;2:471—476.
10.
Tucker T., Friedman TM: Pathogenesis of hereditary tumors: Beyond the “two-hit” hypothesis . Clin Genet2002;62:345—357.
11.
Crino P., Helske E.: New developments in the neurobiology of the tuberous sclerosis complex. Neurology1999;53:1384—1390.
12.
Onda H., Crino P., Zhang H., et al: TSC2 null murine neuroepithelial cells are a model for human tuber giant cells and show activation of an mTOR pathway. Mol CellNeurol Sci2002;21: 561—574.
13.
Gomez M, Sampson J, Whittemore VH (eds): The Tuberous Sclerosis Complex. Oxford, UK, Oxford University Press, 1999.
14.
Griffiths PD , Martland TR: Tuberous sclerosis complex: The role of neuroradiology . Neuropediatrics1997;28:244—252.
15.
Rott HD, Lemeke B., Zenker M., et al. Cyst-like cerebral lesions in tuberous sclerosis. Am J Med Genet2002;111:435—439.
16.
Bourneville D-M.: Sclerose tubereuse des circonvolutions cerebrales: Idiotie et epilepsie hemiplegique. Arch Neurol (Paris) 1880;81—91.
17.
Goodman M., Lamm SH, Engel A., et al: Cortical tuber count: A bio-marker indicating severity of tuberous sclerosis complex. J Child Neurol1997;12:85—90.
18.
Shepherd CW , Houser OW, Gomez MR: MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. AJNR Am J Neuroradiol1995;16:149—155.
19.
Inoe Y., Nemoto Y., Murata R., et al: CT and MR imaging of cerebral tuberous sclerosis. Brain Dev1998;20:209—221.
20.
Christopher C., Sekhara T., Rypens F., et al: MRI spectrum of cortical malformations in tuberous sclerosis complexBrain Dev2000 ;22:487—493.
21.
Guerrini R. , Carrozzo R.: Epileptogenic brain malformations: clinical presentation, malformative patterns, and indications for genetic testing. Seizure2001;10:532—547.
22.
Iwasaki S., Nakagawa H., Kichikawa K., et al: MR and CT of tuberous sclerosis: Linear abnormalities in the cerebral white matter. AJNR Am J Neuroradiol1990;11:1029—1034.
23.
Vigliano P. , Canavese C., Bobba B., et al: Transmantle dysplasia in tuberous sclerosis: Clinical features and surgical outcome in four children. J Child Neurol2002:17:752—758.
24.
Woo Clf, Chuang SH, Becker LE, et al: Radiologic pathologic correlation in focal cortical dysplasia and hemimegalencephaly in 18 children. Pediatr Neurol2001; 25: 295—303.
25.
Galluzzi P. , Cerase A., Stramski M., et al: Hemimegalencephaly in tuberous sclerosis complex. J Child Neurol2002;17:677—680.
26.
Beltramello A., Puppini G., Bricolo A., et al: Does tuberous sclerosis complex include intracranial aneurysms?Pediatr Radiol1999 ;29:206—211.
27.
Imaizumi M. , Nukala T., Yoneda S., et al: Tuberous sclerosis with moya moya disease. Case report. Med J Osaka Univ1978 ;28: 345—353.
28.
Sener RN: Cerebellar involvement in tuberous sclerosis. Comp Med Imaging Graphics1998;22:63—65.
29.
DiMario FJ: Brainstem tubers presenting as disordered breathing in tuberous sclerosis complex. J Child Neurol1995; 10:406-409.
30.
Palmini A., Amdermann F., Tampieri D., et al: Epilepsy and cortical cytoarchitectonic abnormalities: An attempt at correlating basic mechanisms with anatomo-clinical syndromes. Epilepsy Res1992;Suppl 9:10—18.
31.
Vinters HV, Kerfoot C., Catania M., et al: Tuberous sclerosis-related gene expression in normal and dysplastic brain. Epilepsy Res1998;32:12—23.
32.
Guerreiro MM , Andermann F., Andermann E., et al: Surgical treatment of epilepsy in tuberous sclerosis: Strategies and results in 18 patients. Neurology1998;51:1263—1269.
33.
McKay MT, Becker LE, Chriang SH, et al: Malformations of cortical development with balloon cells: Clinical and radiologic correlates. Neurology2003;60:580—587.
34.
Knudson A.: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A1971;68:820—823.
35.
Tucker T., Friedman JM: Pathogens of hereditary tumors: Beyond the “two-hit” hypothesis . Clin Genet2002;62:345—357.
36.
Uhlmann EJ, Wong M., Baldwin RL, et al: Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol2002;52:285—296.
37.
Uhlmann EJ, Apicelli AJ, Beldwin RL: Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/—cells . Oncogene2002;21:4050—4059.
38.
Crino PB: Molecular pathogenesis of tubular formation in tuberous sclerosis complex . J Child Neurol2004; 19:716-725.
39.
Yorns W., Burleson JA, DiMario FJ: Brain morphometry in tuberous sclerosis complex. J Invest Med2001;49:221A.
40.
Ridler K., Bullmore E., Devries P., et al: Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol Med2001;31:1437—1446.
